Background Non‐alcoholic fatty liver disease (NAFLD) affects 15–40% of the general
population. Some patients have non‐alcoholic steatohepatitis (NASH) and progressive …

Non-alcoholic fatty liver disease (NAFLD) affects one in every three subjects in the
occidental world. The vast majority will not progress, but a relevant minority will develop liver …

Non-alcoholic fatty liver disease (NAFLD) refers to the accumulation of hepatic steatosis not
due to excess alcohol consumption. The prevalence of NAFLD is up to 30% in developed …

Aliment Pharmacol Ther 2011; 33: 525–540 Summary Background Non‐alcoholic fatty liver
disease (NAFLD) has become the most prevalent cause of liver disease in Western …

Nonalcoholic fatty liver disease (NAFLD) is quickly becoming one of the most prominent
causes of liver disease worldwide. The increasing incidence of NAFLD is tied to the obesity …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of elevated liver
function tests results, after the commonly investigated causes have been excluded, and …

Prolidase (peptidase D), encoded by the PEPD gene, is a ubiquitously expressed cytosolic
metalloproteinase, the only enzyme capable of cleaving imidodipeptides containing C …

BACKGROUND: Liver biopsy is the reference standard for diagnosing the extent of fibrosis
in chronic liver disease; however, it is invasive, with the potential for serious complications …

Nonalcoholic fatty liver disease is a common medical condition worldwide and its
prevalence has increased notably in the past few years due to the increases in prevalence …

The prevalence of non-alcoholic fatty liver disease (NAFLD) is estimated to be 25-30% of the
population, and is the most common cause of elevated liver enzymes in Korea. NAFLD is a …